Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | TSHR | P16473 | 7/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15137877 | 0.87 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL9753769 | 0.86 | CYP3A4 (0.44) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL15138810 | 0.86 | CYP3A4 (0.44) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL5145421 | 0.84 | ALDH1A1 (0.48) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL14947844 | 0.81 | ATM (0.42) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL18124416 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL16613790 | 0.80 | ALDH1A1 (0.45) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL9306882 | 0.79 | ALDH1A1 (0.48) | ALDH1A1CYP3A4LMNAMAPK1HSD17B10 | |
| SCHEMBL22342142 | 0.79 | TSHR (0.48) | ALDH1A1TSHRCYP3A4LMNAMAPK1 | |
| SCHEMBL9679694 | 0.79 | ATM (0.39) | ALDH1A1TSHRCYP3A4LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815485-B2 | Azo compound, pigment dispersant containing the azo compound, pigment composition, pigment dispersion, and toner | CANON KABUSHIKI KAISHA (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8815485-B2 | Azo compound, pigment dispersant containing the azo compound, pigment composition, pigment dispersion, and toner | CANON KABUSHIKI KAISHA (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20130122413-A1 | AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER | CANON KABUSHIKI KAISHA (JP) | 2013-05-16 | — | — | US | disclosed |
| US-20130122413-A1 | AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER | CANON KABUSHIKI KAISHA (JP) | 2013-05-16 | — | — | US | disclosed |
| WO-2012026378-A1 | AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER | CANON KABUSHIKI KAISHA (JP) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130122413-A1 | AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER | TYR, CRY1, MITF | ALDH1A1 1826/4885TSHR 2792/4885CYP3A4 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.